LGALS1 and cervical cancer: In a study, ex vivo-expanded γδ T cells, derived from tumor-infiltrating lymphocytes, demonstrated significant cytotoxicity against cervical cancer cells in vitro, which was further enhanced by the addition of an anti-Gal-1 antibody [185].